This is expected to significantly reduce the turnaround time, standardise reporting quality and increase efficiency multi-fold
Thyrocare adopts SigTuple’s AI100 to to automate the manual microscopy process across its network.
This is expected to significantly reduce the turnaround time, standardise reporting quality and increase efficiency multi-fold.
Rahul Guha, Managing Director , Thyrocare Technologies said, “Digitalising microscopy has the potential to transform the face of diagnostics throughout India, and AI-integration in diagnostics is a game-changer. It has brought remarkable precision to our diagnostic capabilities. With the flagship product SigTuple AI100, we can now provide more accurate results, increased productivity, reduced TAT, and all this at lower costs.”
Thyrocare is in the process of expanding its presence across tier-2/3 cities and towns. Digital microscopy with artificial intelligence will be an enabler in a big way to do peer review on abnormal samples reporting and diagnosing several critical disorders like malarial infections, cancers, etc. Artificial intelligence brings down the scan time significantly which gives leverage to labs to report quickly. The scan data is available for secondary opinion, sharing with clinicians in a digital format.
SigTuple AI100 is the solution for AI-assisted digital pathology.
Dr Tathagato Rai Dastidar, Founder & CEO, SigTuple commented on the association, “SigTuple started in 2015 with a singular goal – to make quality healthcare more accessible, more accurate and more affordable. AI100 was built to solve the problem of digital pathology with that aim in mind. We are very excited to see that vision coming true in real life, and that our product is now being deployed by most of the key laboratory networks in the country.”
As a pilot, installations have been done in the Thyrocare labs at Lucknow, Nagpur and Ranchi where a panel of doctors are already using the technology to serve patients in reduced turnaround time.
- Advertisement -